Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,520 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Natural and induced T regulatory cells in cancer.
Adeegbe DO, Nishikawa H. Adeegbe DO, et al. Among authors: nishikawa h. Front Immunol. 2013 Jul 11;4:190. doi: 10.3389/fimmu.2013.00190. eCollection 2013. Front Immunol. 2013. PMID: 23874336 Free PMC article.
Regulatory T cells in cancer immunotherapy.
Nishikawa H, Sakaguchi S. Nishikawa H, et al. Curr Opin Immunol. 2014 Apr;27:1-7. doi: 10.1016/j.coi.2013.12.005. Epub 2014 Jan 14. Curr Opin Immunol. 2014. PMID: 24413387 Review.
Regulatory T cells in cancer; can they be controlled?
Adeegbe DO, Nishikawa H. Adeegbe DO, et al. Among authors: nishikawa h. Immunotherapy. 2015;7(8):843-6. doi: 10.2217/imt.15.52. Epub 2015 Aug 28. Immunotherapy. 2015. PMID: 26316166 Free article. No abstract available.
Hypomethylation of the Treg-Specific Demethylated Region in FOXP3 Is a Hallmark of the Regulatory T-cell Subtype in Adult T-cell Leukemia.
Shimazu Y, Shimazu Y, Hishizawa M, Hamaguchi M, Nagai Y, Sugino N, Fujii S, Kawahara M, Kadowaki N, Nishikawa H, Sakaguchi S, Takaori-Kondo A. Shimazu Y, et al. Among authors: nishikawa h. Cancer Immunol Res. 2016 Feb;4(2):136-45. doi: 10.1158/2326-6066.CIR-15-0148. Epub 2015 Dec 17. Cancer Immunol Res. 2016. PMID: 26681759
Roles of regulatory T cells in cancer immunity.
Takeuchi Y, Nishikawa H. Takeuchi Y, et al. Among authors: nishikawa h. Int Immunol. 2016 Aug;28(8):401-9. doi: 10.1093/intimm/dxw025. Epub 2016 May 9. Int Immunol. 2016. PMID: 27160722 Free PMC article. Review.
Effector Regulatory T Cells Reflect the Equilibrium between Antitumor Immunity and Autoimmunity in Adult T-cell Leukemia.
Ureshino H, Shindo T, Nishikawa H, Watanabe N, Watanabe E, Satoh N, Kitaura K, Kitamura H, Doi K, Nagase K, Kimura H, Samukawa M, Kusunoki S, Miyahara M, Shin-I T, Suzuki R, Sakaguchi S, Kimura S. Ureshino H, et al. Among authors: nishikawa h. Cancer Immunol Res. 2016 Aug;4(8):644-9. doi: 10.1158/2326-6066.CIR-15-0303. Epub 2016 May 23. Cancer Immunol Res. 2016. PMID: 27215229
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody.
Ha D, Tanaka A, Kibayashi T, Tanemura A, Sugiyama D, Wing JB, Lim EL, Teng KWW, Adeegbe D, Newell EW, Katayama I, Nishikawa H, Sakaguchi S. Ha D, et al. Among authors: nishikawa h. Proc Natl Acad Sci U S A. 2019 Jan 8;116(2):609-618. doi: 10.1073/pnas.1812186116. Epub 2018 Dec 26. Proc Natl Acad Sci U S A. 2019. PMID: 30587582 Free PMC article.
Novel anti-GARP antibody DS-1055a augments anti-tumor immunity by depleting highly suppressive GARP+ regulatory T cells.
Satoh K, Kobayashi Y, Fujimaki K, Hayashi S, Ishida S, Sugiyama D, Sato T, Lim K, Miyamoto M, Kozuma S, Kadokura M, Wakita K, Hata M, Hirahara K, Amano M, Watanabe I, Okamoto A, Tuettenberg A, Jonuleit H, Tanemura A, Maruyama S, Agatsuma T, Wada T, Nishikawa H. Satoh K, et al. Among authors: nishikawa h. Int Immunol. 2021 Jul 23;33(8):435-446. doi: 10.1093/intimm/dxab027. Int Immunol. 2021. PMID: 34235533
1,520 results